ArriVent BioPharma, Inc. (AVBP)
NASDAQ: AVBP · Real-Time Price · USD
16.73
+0.02 (0.12%)
At close: Oct 9, 2026, 4:00 PM EDT
16.57
-0.16 (-0.96%)
After-hours: Oct 9, 2026, 7:46 PM EDT
ArriVent BioPharma Analyst Ratings
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| H.C. Wainwright | H.C. Wainwright | Buy Reiterates $47 → $27 | Buy | Reiterates | $47 → $27 | +61.39% | Oct 8, 2026 |
| Guggenheim | Guggenheim | Buy Reiterates $45 → $18 | Buy | Reiterates | $45 → $18 | +7.59% | Oct 7, 2026 |
| Citi | Citi | Buy Maintains $40 → $20 | Buy | Maintains | $40 → $20 | +19.55% | Oct 7, 2026 |
| BTIG | BTIG | Buy Reiterates $42 → $29 | Buy | Reiterates | $42 → $29 | +73.34% | Oct 7, 2026 |
| Clear Street | Clear Street | Buy Maintains $47 → $22 | Buy | Maintains | $47 → $22 | +31.50% | Oct 6, 2026 |
| JonesTrading | JonesTrading | Buy Reiterates $45 → $22 | Buy | Reiterates | $45 → $22 | +31.50% | Oct 6, 2026 |
| Truist Financial | Truist Financial | Buy Maintains $45 → $18 | Buy | Maintains | $45 → $18 | +7.59% | Oct 6, 2026 |
| Jefferies | Jefferies | Buy Maintains $45 → $18 | Buy | Maintains | $45 → $18 | +7.59% | Oct 6, 2026 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 3 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.